|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$8.65 |
$8.98 |
$8.65 |
$8.85 |
1.00M | 04/22/2024 |
$8.88 |
$8.98 |
$8.64 |
$8.71 |
720.00K | 04/23/2024 |
$8.76 |
$8.93 |
$8.54 |
$8.56 |
486.70K | 04/24/2024 |
$8.71 |
$8.71 |
$8.47 |
$8.55 |
588.70K | 04/25/2024 |
$8.46 |
$8.49 |
$8.09 |
$8.11 |
881.40K |
|
Zymeworks is a clinical-stage biopharmaceutical company focused on the development of multifunctional biotherapeutics. Co.'s primary product candidate, zanidatamab, is a bispecific (dual-targeting) antibody that targets two domains of the human epidermal growth factor receptor 2. Co.'s second product candidate, ZW49, combines the design of zanidatamab with its ZymeLink antibody-drug conjugate platform, comprised of its proprietary cytotoxin (cancer cell-killing compound) and cleavable linker. Co. is also developing a pipeline of preclinical product candidates and discovery-stage programs in oncology (including immuno-oncology agents) and other therapeutic areas. | |
|
Zymeworks (ZYME) has the following price history information. Looking back at ZYME historical stock prices for the last five trading days, on April 19, 2024, ZYME opened at $8.65, traded as high as $8.98 and as low as $8.65, and closed at $8.85. Trading volume was a total of 1.00M shares. On April 22, 2024, ZYME opened at $8.88, traded as high as $8.98 and as low as $8.64, and closed at $8.71. Trading volume was a total of 720.00K shares. On April 23, 2024, ZYME opened at $8.76, traded as high as $8.93 and as low as $8.54, and closed at $8.56. Trading volume was a total of 486.70K shares. On April 24, 2024, ZYME opened at $8.71, traded as high as $8.71 and as low as $8.47, and closed at $8.55. Trading volume was a total of 588.70K shares. On April 25, 2024, ZYME opened at $8.46, traded as high as $8.49 and as low as $8.09, and closed at $8.11. Trading volume was a total of 881.40K shares.
ZYME Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zymeworks shares, starting with a $10,000 purchase of ZYME, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/01/2017 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$13.07 |
|
End price/share: |
$8.11 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-37.95% |
|
Average Annual Total Return: |
-6.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,205.16 |
|
Years: |
6.99 |
|
|
|
Date |
Close |
04/19/2024 | $8.85 | 04/22/2024 | $8.71 | 04/23/2024 | $8.56 | 04/24/2024 | $8.55 | 04/25/2024 | $8.11 |
|
|